Treprostinil
|
|
- CAS-Nr.
- 81846-19-7
- Englisch Name:
- Treprostinil
- Synonyma:
- TREPROSTINIL;Orenitram;2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetic acid;UT-15;LRX 15;U 62840;15AU-81;BW 15AU;Uniprost;Ruidulin
- CBNumber:
- CB7231250
- Summenformel:
- C23H34O5
- Molgewicht:
- 390.51
- MOL-Datei:
- 81846-19-7.mol
|
Treprostinil Eigenschaften
- Schmelzpunkt:
- 121-123°
- Siedepunkt:
- 587.1±50.0 °C(Predicted)
- Dichte
- 1.158±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- L?slichkeit
- Chloroform (Slightly, Heated), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 3.19±0.10(Predicted)
- Farbe
- Off-White to Beige
- InChIKey
- PAJMKGZZBBTTOY-ZFORQUDYSA-N
- SMILES
- C(O)(=O)COC1=C2C(=CC=C1)C[C@@]1([H])[C@@]([H])(C2)C[C@@H](O)[C@@H]1CC[C@@H](O)CCCCC
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H301 |
Giftig bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P264, P270, P301+P310, P321, P330,P405, P501 |
H311 |
Giftig bei Hautkontakt. |
Akute Toxizit?t dermal |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P280, P302+P352, P312, P322, P361,P363, P405, P501 |
H331 |
Giftig bei Einatmen. |
Akute Toxizit?t inhalativ |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P261, P271, P304+P340, P311, P321,P403+P233, P405, P501 |
H361 |
Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Reproduktionstoxizit?t |
Kategorie 2 |
Warnung |
|
P201, P202, P281, P308+P313, P405,P501 |
|
Sicherheit |
P201 |
Vor Gebrauch besondere Anweisungen einholen. |
P202 |
Vor Gebrauch alle Sicherheitshinweise lesen und verstehen. |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
P308+P313 |
BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen. |
P405 |
Unter Verschluss aufbewahren. |
P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Treprostinil Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Synthetic analog of Prostacyclin (P839060). Antihypertensive. Treprostinil, marketed under the trade name Remodulin is a medication used to treat pulmonary arterial hypertension (PAH).
Pharmakokinetik
Treprostinil is
rapidly absorbed from the subcutaneous site of infusion, with an almost 100% bioavailability and a mean half-life of 85
minutes (34 minutes for the IV infusion). The IV solution must be diluted with normal saline or sterile water before
starting the infusion. Unlike epoprostenol, treprostinil is stable at room temperature for up to 5 years, with vasodilation
action lasting from 4 to 6 hours, compared with the short, 2- to 3-minute action for epoprostenol. Because of its long
life in the body, it can be administered under the skin with a microinfusion subcutaneous infusion pump rather than into
the bloodstream and, thus, without hospitalization, as contrasted with the central IV infusion of epoprostenol.
Clinical Use
Treprostinil is a synthetic, stable form of prostacyclin for the treatment for advanced pulmonary
hypertension with NYHA class III or IV symptoms as well as for late-stage peripheral vascular disease (PVD). Its sodium
salt injectable form is administered either as a continuous subcutaneous infusion directly into the skin or, if the
subcutaneous infusion is not tolerated, as a continuous IV infusion without an implanted catheter.
Nebenwirkungen
Side effects include jaw pain, headaches, nausea, diarrhea, flushing, and localized pain at the delivery site under the
skin. This pain has been reported as slight to severe irritation. Patients using the drug seem to ex-perience
improvement in their condition, including decreased fatigue, decreased shortness of breath, and decreased pulmonary
artery pressures, as well as overall improvement in quality of life.
Synthese
A 250-mL, round-bottom flask with a magnetic stirrer was charged with treprostinil diethanolamine salt (4 g) and water (40 mL). The mixture was stirred to obtain a clear solution. Ethyl acetate (100 mL) was added to the clear solution. While stirring, 3M HCl (3.2 mL) was added slowly until pH=1 was attained. The mixture was stirred for 10 minutes, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2×100 mL). The combined organic layers were washed with water (2×100 mL) and brine (1×50 mL) and dried over anhydrous Na2SO4. The ethyl acetate solution of treprostinil was filtered, and the filtrate was concentrated under a vacuum at 50° C. to give an off-white solid. The crude treprostinil was recrystallized from 50% ethanol in water (70 mL). The pure treprostinil was collected in a Buchner funnel by filtration, and the cake was washed with a cold 20% ethanolic solution in water. The cake of treprostinil was air-dried overnight and further dried in a vacuum oven at 50° C under high vacuum to afford 2.9 g of treprostinil (Yield 91.4%).
Treprostinil Upstream-Materialien And Downstream Produkte
Upstream-Materialien
2-[2-[(E)-2-[4-(dimethylamino)phenyl]ethenyl]-6-methylpyran-4-ylidene]propanedinitrile
(S)-1-CHLOROHEPTAN-2-OL
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid,2-(2-hydroxyethylamino)ethanol
101692-03-9
Treprostinil Methyl Ester
2-ALLYL-3-HYDROXYBENZALDEHYDE
Treprostinil Ethyl Ester
(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol
Downstream Produkte
Treprostinil Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 167)Lieferanten
81846-19-7()Verwandte Suche:
- 2-[[[(1R,2R,3aS,9aS)-2α-Hydroxy-1β-[(S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indene]-5-yl]oxy]acetic acid
- UT-15
- [[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]acetic acid
- Treprostinil Sodium intermediate
- [1R-[1α(S*),2β,3aα,9aα]]-
- 2-[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]acetic Acid
- Acetic acid, 2-[[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl]oxy]-
- REMODULIN
- U 62840
- [[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-1-[(S)-3-hydroxyoctyl]-1H-benzo[f]indene-5-yl]oxy]acetic acid
- [[[(1R)-2,3,3aβ,4,9,9aβ-Hexahydro-2α-hydroxy-1-[(S)-3-hydroxyoctyl]-1H-benz[f]inden]-5-yl]oxy]acetic acid
- 15AU-81
- Treprostinil-13C2-d1
- Treprostinil free acid
- BW 15AU
- BW 15AU;LRX 15;RUMODOLIN;U-62840;UNIPROST
- LRX 15
- Rumodolin
- Uniprost
- Treprostinil(W.S)
- Treprostinil (LRX-15)
- Remodulin Treprostinil
- Treprostinil (Ut-15)
- REMODULIN USP/EP/BP
- TreprostinilQ: What is
Treprostinil Q: What is the CAS Number of
Treprostinil Q: What are the applications of
Treprostinil
- TREPROSTINIL
- Orenitram
- 2-(((1R,2R,3aS,9aS)-2-hydroxy-1-((S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl)oxy)acetic acid
- Ruidulin
- 81846-19-7
- Aromatics
- Chiral Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals